Published: 2021-05-25

Tuberous sclerosis complex associated neuropsychiatric disorder in children: experience sharing from a tertiary care hospital

Kanij Fatema, Mizanur Rahman, Shaheen Akhter, Roushan Jahan


Background: Tuberous sclerosis complex (TSC) is a genetic disorder where there is multisystem involvement. Most important manifestations are neurological and psychiatric disorders. These disorders should be detected timely and addressed adequately. The common psychiatric disorders are autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), intellectual disability (ID), learning disorder etc. This study has been done to describe the pattern of psychiatric disorders in children with TSC.

Methods: This is an observational study taken place in a tertiary care hospital taken place on Children of 0-18 years of age. The study subjects were 84 patients with TSC. Detail history and physical examination had been done along with neuroimaging, EEG and target organs screening. Different psychometric tool was used for psychiatric evaluation.  

Results: Total 84 patients were included in this study, mean age was 7+3.96 years, 54% were female. Physical finding were as follows: ash leaf spot, shagreen patch, adenoma sebaceum, cafe au lait spot, rhabdomyoma, renal cyst and angiomyolipoma etc.  Seventy patients had epilepsy, most common being focal epilepsy (45.7%), 17.1% had epileptic spasm. Fifty percent patients had developmental delay. Regarding psychiatric disorders, most common disorder was ADHD in 27.38%, ASD in 23.81% and both in 10.71%. ID was found in 20.24% study subjects. Early onset of seizure was associated with more psychiatric disorders.

Conclusions: Neuropsychiatric manifestations of TSC are diverse and often are poorly addressed. The most commonly found disorders in this study were ADHD, ASD and ID. Early onset of seizure was associated with the psychiatric disorders in TSC.


Tuberous sclerosis complex, Neuropsychiatric disorder, Children

Full Text:



Julich K, Sahin M. Mechanism-based treatment in tuberous sclerosis complex. Pediatr Neurol. 2014;50(4):290-6.

Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet. 2008;372(9639):657-68.

Curatolo P, Moavero R, Vries PJ. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol. 2015;14:733-45.

Vries PJ, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P, et al. Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders (TAND): New Findings on Age, Sex, and Genotype in Relation to Intellectual Phenotype. Front Neurol. 2020;11:603.

Vries PJ, Whittemore VH, Leclezio L, Byars AW, Dunn D, Ess KC, et al. Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND checklist. Pediatr Neurol. 2015;52:25-35.

Krueger DA, Northrup H, International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49(4):255-65.

Vries PJ, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P, Dahlin M, et al. TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study. Orphanet J Rare Dis. 2018;13(1):157.

Vries, PJ. Neurodevelopmental, psychiatric and cognitive aspects of tuberous sclerosis complex. In: Kwiatkowski, DJ, Whittemore VH, Thiele EA, eds. Tuberous Sclerosis Complex: Genes, Clinical Features and Therapeutics. Weinheim, Germany: Wiley-Blackwell; 2010. 229-267.

Vries PJ. Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex. Neurotherapeutics. 2010;7:275-82.

Kwiatkowski DJ, Manning BD. Tuberous sclerosis: a GAP at the crossroad of multiple signaling pathways. Hum Mol Genet. 2005;14(2):251-8.

Northrup H, Krueger DA, International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol. 2013;49(4):243-54.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.

Kingswood JC, Augeres GB, Belousova E, Ferreira JC, Carter T, Castellana R, et al. Tuberous Sclerosis registry to increase disease Awareness (TOSCA)- baseline data on 2093 patients. Orphanet J Rare Dis. 2017;12(1):2.

Leclezio L, Jansen A, Whittemore VH, Vries PJ. Pilot validation of the tuberous sclerosis-associated neuropsychiatric disorders (TAND) checklist. Pediatr Neurol. 2015;52:16-24.

Vries PJ, Hunt A, Bolton PF. The psychopathologies of children and adolescents with tuberous sclerosis complex (TSC): a postal survey of UK families. Eur Child Adolesc Psychiatry. 2007;16:16-24.

Tsai P, Sahin M. Mechanisms of neurocognitive dysfunction and therapeutic considerations in tuberous sclerosis complex. Curr Opin Neurol. 2011;24:106-13.

Muzykewicz DA, Newberry P, Danforth N, Halpern EF, Thiele EA. Psychiatric comorbid conditions in a clinic population of 241 patients with tuberous sclerosis complex. Epilepsy Behav. 2007;11(4):506-13.

Hunt A. A comparison of the abilities, health and behaviour of 23 people with tuberous sclerosis at age 5 and as adults. J App Res in Intel Disab. 1998;11(3):227-38.

Joinson C, Callaghan FJ, Osborne JP, Martyn C, Harris T, Bolton PF. Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex. Psychol Med. 2003;33(2):335-44.

Bolton PF, Clifford M, Tye C, Maclean C, Humphrey A, Marechal K, Higgins JN, et al. Intellectual abilities in tuberous sclerosis complex: risk factors and correlates from the Tuberous Sclerosis 2000 Study. Psychol Med. 2015;45(11):2321-31.

Van EAM, Black ME, Pulsifer MB, Kwiatkowski DJ, Thiele EA. Genotype and cognitive phenotype of patients with tuberous sclerosis complex. Eur J Hum Genet. 2012;20(5):510-5.

Van EAM, Chu SCJ, Pulsifer MB, Camposano SE, Thiele EA. Cognitive and adaptive development of patients with tuberous sclerosis complex: a retrospective, longitudinal investigation. Epilepsy Behav. 2012;23(1):10-5.

Wong HT, Cartney DL, Lewis JC, Sampson JR, Howe CJ, Vries PJ. Intellectual ability in tuberous sclerosis complexcorrelates with predicted effects of mutations on TSC1 and TSC2 proteins. J Med Gen. 2015;52(12):815-22.

Agati E, Moavero R, Cerminara C, Curatolo P. Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex. J Child Neurol. 2009;24(10):1282-7.

Moavero R, Marciano S, Pro S, Stefano D, Vigevano F, Curatolo P, et al. Event-Related Potentials in ADHD Associated With Tuberous Sclerosis Complex: A Possible Biomarker of Symptoms Severity?. Front Neurol. 2020;10;11:546.

Gipson TT, Gerner G, Wilson MA, Blue ME, Johnston MV. Potential for treatment of severe autism in tuberous sclerosis complex. World J Clin Pediatr. 2013;2(3):16-25.

Vignoli A, Briola F, Turner K, Scornavacca G, Chiesa V, Zambrelli E, et al. Epilepsy in TSC: certain etiology does not mean certain prognosis. Epilepsia. 2013;54(12):2134–42.

Kaczorowska M, Jurkiewicz E, Domanska PD, Syczewska M, Lojszczyk B, Chmielewski D, et al. Cerebral tuber count and its impact on mental outcome of patients with tuberous sclerosis complex. Epilepsia. 2011;52(1):22–7.

Numis AL, Major P, Montenegro MA, Muzykewicz DA, Pulsifer MB, Thiele EA. Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex. Neurology. 2011;76:981-7.

Van EAM, Pulsifer MB, Merker VL, Neumeyer AM, Van EEE, Thibert RL, et al. Understanding relationships between autism, intelligence, and epilepsy: a cross-disorder approach. Dev Med Child Neurol. 2013;55(2):146-53.

Vries PJ. The psychopathologies of attention in tuberous sclerosis. University of Cambridge; 2002.

Carlisle KW. School Factors Related to the Social and Behavioral Success of Children and Adolescents with Tuberous Sclerosis: Special Education Placement, Services, and Parental Involvement. University of South Florida: Graduate Theses and Dissertations; 2003.

Prather P, Vries PJ. Behavioral and cognitive aspects of tuberous sclerosis complex. J of Child Neurol. 2004;19(9):666-74.

Curatolo P, Aronica E, Jansen A, Jansen F, Kotulska K, Lagae L. Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC. European J of Paed Neurol. 2016;20(2):203-11.

Vries PJ, Hunt A, Bolton PF. The psychopathologies of children and adolescents with tuberous sclerosis complex (TSC): a postal survey of UK families. Eur Child Adolesc Psychiatry. 2007;16(1):16-24.

Prabowo AS, Anink JJ, Lammens M, Nellist M, Ouweland AM, Adle BH, et al. Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation. Brain Pathol. 2013;23(1):45-59.

Bolton PF, Park RJ, Higgins JN, Griffiths PD, Pickles A. Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain. 2002;125(6):1247-55.

Moavero R, Napolitano A, Cusmai R, Vigevano F, Figa TL, Calbi G, et al. White matter disruption is associated with persistent seizures in tuberous sclerosis complex. Epilepsy Behav. 2016;60:63-7.

Cusmai R, Moavero R, Bombardieri R, Vigevano F, Curatolo P. Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis. Epilepsy Behav. 2011;22(4):735-9.

Zaroff CM, Barr WB, Carlson C, La JJ, Madhavan D, Miles DK, et al. Mental retardation and relation to seizure and tuber burden in tuberous sclerosis complex. Seizure. 2006;15(7):558-62.

Rahman MM, Fatema K. Epilepsy in Children with Tuberous Sclerosis Complex: A Prospective Observational Study in Bangladesh. J Epilep Res. 2020;10(1):18-23.

Waele L, Lagae L, Mekahli D. Tuberous sclerosis complex: the past and the future. Pediatr Nephrol. 2015:30,1771-80.

Kingswood C, Bolton P, Crawford P, Harland C, Johnson SR, Sampson JR, et al. The clinical profile of tuberous sclerosis complex (TSC) in the United Kingdom: A retrospective cohort study in the Clinical Practice Research Datalink (CPRD). Eur J Paediatr Neurol. 2016;20(2):296-308.